Amyotrophic lateral sclerosis: Analysis of ALS cases in a predominantly admixed population of Ecuador

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 15, Issue 1-2, 2014, Pages 106-113

  Bucheli, Miriam ^a   Andino, Andres ^b   Montalvo, Mayra ^b   Cruz, Jose ^b   Atassi, Nazem ^c   Berry, James ^c   Salameh, Johnny ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSIDAD SAN FRANCISCO DE QUITO   (Ecuador)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

ALS; ALS diagnosis; Ecuador; EMG; South America

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; DIAGNOSTIC ERROR; ELECTROMYOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIDDLE AGED; ONSET AGE; PRIORITY JOURNAL; VERY ELDERLY;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; COHORT STUDIES; ECUADOR; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE;

EID: 84895525272     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2013.852590     Document Type: Article

References (62)

1. Brain WR, Walton JN. Brain's diseases of the nervous system. 1969. London: Oxford University Press .
2. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001;344:1688-700. (Pubitemid 32479968)
3. Rowland LP. How amyotrophic lateral sclerosis got its name: the clinical-pathologic genius of Jean-Martin Charcot. Arch Neurol. 2001;58:512-5. (Pubitemid 32217472)
4. Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009;4:3.
5. Wijesekera LC, Mathers S, Talman P, Galtrey C, Parkinson MH, Ganesalingam J, et al. Natural history and clinical features of the flail arm and flail leg ALS variants . Neurology. 2009;72:1087-94.
6. Hu MT, Ellis CM, Al-Chalabi A, Leigh PN, Shaw CE. Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1998;65: 950-1.
7. Gordon PH, Cheng B, Katz IB, Pinto M, Hays AP, Mitsumoto H, et al. The natural history of primary lateral sclerosis. Neurology. 2006;66:647-53. (Pubitemid 43739816)
8. Ince PG, Lowe J, Shaw PJ. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol Appl Neurobiol. 1998;24:104-17. (Pubitemid 28175040)
9. Forbes RB, Colville S, Swingler RJ. The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 years or above. Age Ageing. 2004;33:131-4. Epub 2004/02/13. (Pubitemid 38313110)
10. Silani V, Messina S, Poletti B, Morelli C, Doretti A, Ticozzi N, et al. The diagnosis of amyotrophic lateral sclerosis in 2010. Arch Ital Biol. 2011;149:5-27.
11. Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G. Incidence of ALS in Lombardy, Italy. Neurology. 2007; 68:141-5. Epub 2007/01/11.
12. Dietrich-Neto F, Callegaro D, Dias-Tosta E, Almeida Silva H, Ferraz ME , Braz de Lima JM, Souza Bulle Oliviera A. Amyotrophic Lateral Sclerosis in Brazil 1998 National Survey. Arq Neuropsiquiatr. 2000;58:607-15.
13. Mitchell J D , Borasio G D. Amyotrophic lateral sclerosis. Lancet. 2007;369:2031-41.
14. Lang B. Amyotrophic Lateral Sclerosis. 2008:417-20.
15. Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79:6-11.
16. Massman PJ, Sims J, Cooke N, Haverkamp LJ, Appel V, Appel SH. Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1996;61:450-5. (Pubitemid 26394900)
17. Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology. 2003;60:1094-7. (Pubitemid 36418766)
18. Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 2007;6: 994-1003. (Pubitemid 47562321)
19. Strong MJ, Grace GM, Orange JB, Leeper HA, Menon RS, Aere C. A prospective study of cognitive impairment in ALS. Neurology. 1999;53:1665-70. (Pubitemid 29530337)
20. Witgert M, Salamone AR, Strutt AM, Jawaid A, Massman PJ, Bradshaw M, et al. Frontal-lobe mediated behavioral dysfunction in amyotrophic lateral sclerosis. Eur J Neurol. 2010;17:103-10.
21. Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385-90.
22. Worms PM. The epidemiology of motor neuron diseases: a review of recent studies. J Neurol Sci. 2001;191:3-9. (Pubitemid 33035889)
23. Beghi E, Logroscino G, Chio A, Hardiman O, Mitchell D, Swingler R, et al. The epidemiology of ALS and the role of population based registries. Biochim Biophys Acta. 2006; 1762:1150-7. (Pubitemid 44750581)
24. Tysnes O-B. Epidemiology and Management of ALS. Advances in Clinical Neuroscience &Rehabilitation. 2004;4:8-9.
25. Vazquez MC, Ketzoian C, Legnani C, Rega I, Sanchez N, Perna A, et al. Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a population based study. Neuroepidemiology. 2008;30:105-11. (Pubitemid 351501625)
26. Leigh PN, Abrahams S, Al-Chalabi A, Ampong MA, Goldstein LH, Johnson J, et al. The management of motor neuron disease. J Neurol Neurosurg Psychiatry. 2003; 74(Suppl 4):32-47.
27. Chio A. Update on ISI survey: Europe, North America and South America. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(Suppl 1):S9-11.
28. Chio A. ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis. J Neurol. 1999;246(Suppl 3):1-5.
29. Dubrovsky AL, Sica RE. Current treatment pathways in ALS: a South American perspective. Neurology. 1999; 53:S11-6. (Pubitemid 29530307)
30. Gil J, Vazquez MC, Ketzoian C, Perna A, Marin B, Preux PM, et al. Prognosis of ALS: comparing data from the Limousin referral centre, France, and a Uruguayan population. Amyotroph Lateral Scler. 2009;10:355-60.
31. Haverkamp LJ, Appel V, Appel SH. Natural history of amyo-trophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain. 1995;118:707-19.
32. Gordon PH, Mehal JM, Holman RC, Rowland LP, Rowland AS, Cheek JE. Incidence of Amyotrophic Lateral Sclerosis Among American Indians and Alaska Natives. JAMA Neurol. 2013:1-5. Epub 2013/02/27.
33. Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007;68: 1002-7. (Pubitemid 46569133)
34. Cellura E, Spataro R, Taiello AC, La Bella V. Factors affecting the diagnostic delay in amyotrophic lateral sclerosis. Clin Neurol Neurosurg. 2012;114:550-4. Epub 2011/12/16.
35. Zoccolella S, Beghi E, Palagano G, Fraddosio A, Samarelli V, Lamberti P, et al. Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population based study. J Neurol Sci. 2006;250:45-9. (Pubitemid 44679704)
36. Annegers JF, Appel S, Lee JR, Perkins P. Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985-1988. Arch Neurol. 1991;48:589-93. Epub 1991/06/01.
37. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293-9.
38. Douglass CP, Kandler RH, Shaw PJ, McDermott CJ. An evaluation of neurophysiological criteria used in the diagnosis of motor neuron disease. J Neurol Neurosurg Psychiatry. 2010;81:646-9.
39. de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119:497-503.
40. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial 'Clinical limits of amyotrophic lateral sclerosis' workshop contributors. J Neurol Sci . 1994;124(Suppl):96-107.
41. Davenport RJ, Swingler RJ, Chancellor AM, Warlow CP. Avoiding false-positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register. J Neurol Neurosurg Psychiatry. 1996;60:147-51. (Pubitemid 26044186)
42. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Amyotrophic lateral sclerosis mimic syndromes: a population based study. Arch Neurol. 2000;57:109-13. (Pubitemid 30027638)
43. Belsh JM, Schiffman PL. Misdiagnosis in patients with amyotrophic lateral sclerosis. Arch Intern Med. 1990;150: 2301-5. (Pubitemid 20365236)
44. Censos I-INdEy. 2010.
45. Logroscino G, Amon, C. Amyotrophic lateral sclerosis: a global threat with a possible difference in risk across ethnicities. Neurology. 2007:e17.
46. Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population based mortality study. Neurology. 2009;72:1640-5.
47. Noonan CW, White MC, Thurman D, Wong LY. Temporal and geographic variation in United States motor neuron disease mortality, 1969-1998. Neurology. 2005;64: 1215-21. Epub 2005/04/13.
48. Olivares L, Esteban ES, Alter M. Mexican 'resistance' to amyotrophic lateral sclerosis. Arch Neurol. 1972;27: 397-402. Epub 1972/11/01.
49. Castro-Costa CM, Oria RB, Vale OC, Arruda JA, Horta WG, D'Almeida JA, et al. Motor neuron diseases in the university hospital of Fortaleza (North-eastern Brazil): a clinico-demo-graphic analysis of 87 cases. Arq Neuropsiquiatr. 2000;58: 986-99. Epub 2000/12/06.
50. Matos SE, Conde MT, Favero FM, Taniguchi M, Quadros AA, Fontes SV, et al. Mortality rates due to amyo-trophic lateral sclerosis in Sao Paulo City from 2002 to 2006. Arq Neuropsiquiatr. 2011;69:861-6. Epub 2012/02/03.
51. Loureiro MP, Gress CH, Thuler LC, Alvarenga RM, Lima JM. Clinical aspects of amyotrophic lateral sclerosis in Rio de Janeiro, Brazil. J Neurol Sci. 2012;316:61-6. Epub 2012/02/22.
52. Werneck LC, Bezerra R, Silveira Neto O, Scola RH. A clinical epidemiological study of 251 cases of amyotrophic lateral sclerosis in the south of Brazil. Arq Neuropsiquiatr. 2007;65:189-95. Epub 2007/07/04. (Pubitemid 47015930)
53. Marin B, Kacem I, Diagana M, Boulesteix M, Gouider R, Preux PM, et al. Juvenile and adult-onset ALS/MND among Africans: incidence, phenotype, survival. A review. Amyo-troph Lateral Scler. 2012;13:276-83.
54. O'Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry. 2008;79:30-2. Epub 2007/07/20.
55. Swash M. Shortening the time to diagnosis in ALS: the role of electrodiagnostic studies. myotroph Lateral Scler Other Motor Neuron Disord. 2000;1(Suppl 1):S67-72.
56. Brooks BR. Problems in shortening the time to confirmation of ALS diagnosis: lessons from the 1st Consensus Conference, Chicago, May 1998. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(Suppl 1):S3-7. Epub 2001/07/24.
57. Wokke JH. Confounding effects of mimicking disorders in the early diagnosis of amyotrophic lateral sclerosis. Amyo-troph Lateral Scler Other Motor Neuron Disord. 2000;1 (Suppl 1):S61-3. Epub 2001/07/24.
58. Belsh JM. ALS diagnostic criteria of El Escorial revisited: do they meet the needs of clinicians as well as researchers? Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1 (Suppl 1):S57-60. Epub 2001/07/24.
59. Dubrovsky AL. Shortening the time to the diagnosis of amyotrophic lateral sclerosis: role of the neurologist. Amyo-troph Lateral Scler Other Motor Neuron Disord. 2000; 1(Suppl 1):S65-6.
60. Beghi E, Balzarini C, Bogliun G, Logroscino G, Manfredi L, Mazzini L, et al. Reliability of the El Escorial diagnostic criteria for amyotrophic lateral sclerosis. Neu-roepidemiology. 2002;21:265-70. (Pubitemid 36151496)
61. Smith RA. Effects of the early diagnosis of amyotrophic lateral sclerosis on the patient: disadvantages. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1 (Suppl 1):S75-7. Epub 2001/07/24.
62. Chaudhuri KR, Crump S, al-Sarraj S, Anderson V, Cavanagh J, Leigh PN. The validation of El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis: a clinicopathological study. J Neurol Sci. 1995;129(Suppl): 11-2.